Molina Healthcare Q4 2025 Financial Results with 2026 Guidance
Molina Healthcare’s Financial Overview for Q4 and Full Year 2025, with 2026 Guidance Released
LONG BEACH, Calif. – Molina Healthcare, Inc. (NYSE: MOH) has released insights into its financial performance for the fourth quarter and the full year of 2025 alongside its projected financial guidance for 2026. The company reported a GAAP loss per diluted share of $3.15 and an adjusted loss of $2.75 for Q4 2025. Over the full year, it recorded GAAP earnings per diluted share of $8.92 and adjusted earnings of $11.03, encompassing fluctuations in financial pressures and adjustments, detailed in their reconciliation of non-GAAP financial measures.
Financial Performance Summary
Premium revenue for 2025 surged to approximately $43.1 billion, reflecting an 11% increase compared to the previous year. This growth was driven by strategic acquisitions, rate adjustments, and organic expansion. Total revenue for 2025 reached $45.4 billion, up from $40.6 billion in 2024, while GAAP net income was $472 million, down from $1.179 billion in the previous year. The medical care ratio (MCR) increased to 91.7% in 2025 from 89.1% in 2024, indicating rising medical cost pressures.
Operational Insights
CEO Joseph Zubretsky highlighted the company's strong operational foundation amidst Medicaid industry challenges. Despite these hurdles, Molina anticipates an enhancement in its earnings potential, largely attributed to an expected rate restoration. The company remains committed to navigating the complex landscape of payer and provider relations while addressing regulatory compliance requirements.
2026 Financial Guidance
Looking ahead, Molina projects a slight decline in premium revenue to around $42 billion in 2026, primarily due to a strategic reduction in its Marketplace segment. However, anticipated growth from the new Florida CMS contract and improved Medicare premiums are expected to compensate. The company forecasts GAAP earnings per diluted share for 2026 to be at least $3.20, with adjusted earnings not dropping below $5.00 per diluted share, considering challenges tied to new contracts and underperforming sectors.
Strategic Focus and Adjustments
Strategically, Molina plans an exit from Medicare Advantage Part D by 2027, prioritizing its dual eligible Medicare business, which synergizes with their long-term strategic goals. This decision reflects a focus on underwriting efficiency and enhancing claims management processes critical to risk management.
Forward-Looking Statements
Molina underscores that its forward-looking statements are subject to distinct risks and uncertainties that could impact actual results. These risk factors are thoroughly documented in their SEC filings, ensuring compliance with industry standards and regulatory frameworks.
For more information, investors and media representatives can reach Jeffrey Geyer at Jeffrey.Geyer@molinahealthcare.com or Caroline Zubieta at Caroline.Zubieta@molinahealthcare.com.